Phase I, 4-way crossover trial evaluating the pharmacokinetics, pharmacodynamics and tolerability of BIOD 531 versus Humulin R, U-500 and Humalog prandial/basal premixed insulin in volunteers
Phase of Trial: Phase I
Latest Information Update: 19 Sep 2014
Price : $35 *
At a glance
- Drugs Insulin (Primary) ; Insulin neutral protamine lispro/insulin lispro
- Indications Insulin resistance; Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Biodel
- 19 Sep 2014 Results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
- 11 Aug 2014 Status changed from recruiting to completed, according to a Biodel media release.
- 12 Feb 2014 Preliminary results published in Biodel media release.